MLKL and colitis: Some studies have investigated the potential involvement of necroptosis using the pharmacological inhibitor of MLKL, necrosulfonamide (NSA), in the 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced mouse model of colitis (93).